Effectiveness of varicella vaccine in children infected with HIV.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2871955)

Published in J Infect Dis on June 15, 2010

Authors

Moeun Son1, Eugene D Shapiro, Philip LaRussa, Natalie Neu, David E Michalik, Michelle Meglin, Andrea Jurgrau, Wally Bitar, Marietta Vasquez, Patricia Flynn, Anne A Gershon

Author Affiliations

1: Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Articles citing this

Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med (2013) 1.79

The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther (2011) 1.33

Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev (2013) 1.06

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J (2013) 0.88

Varicella zoster vaccines and their implications for development of HSV vaccines. Virology (2013) 0.83

Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant (2011) 0.81

Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques. Vaccine (2010) 0.81

Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am (2014) 0.79

Vaccination in HIV-infected adults. AIDS Patient Care STDS (2014) 0.77

Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens. Adv Virol (2013) 0.76

Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children. Pediatr Infect Dis J (2013) 0.76

In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency. Proc Natl Acad Sci U S A (2016) 0.75

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection. Clin Infect Dis (2015) 0.75

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II. Infect Dis Ther (2017) 0.75

Articles cited by this

Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 4.60

Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA (2006) 2.96

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J (2006) 1.76

The safety profile of varicella vaccine: a 10-year review. J Infect Dis (2008) 1.50

Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell (2004) 1.45

Immunization of HIV-infected children with varicella vaccine. J Pediatr (2001) 1.35

A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis (2008) 1.30

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis (2006) 1.17

Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics (2007) 1.14

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11

Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect Dis (1997) 1.11

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allergy Clin Immunol (2004) 1.03

Articles by these authors

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 11.12

A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84

Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33

Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA (2006) 4.18

Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis (2006) 3.84

Association between a novel human coronavirus and Kawasaki disease. J Infect Dis (2005) 3.71

Training mentors of clinical and translational research scholars: a randomized controlled trial. Acad Med (2014) 3.47

Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88

Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust. Pediatrics (2006) 2.76

Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75

Clinical practice. Lyme disease. N Engl J Med (2014) 2.63

Effectiveness over time of varicella vaccine. JAMA (2004) 2.52

Varicella vaccine--are two doses better than one? N Engl J Med (2002) 2.40

Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis (2008) 2.37

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13

Validity of using an electronic medical record for assessing quality of care in an outpatient setting. Med Care (2005) 1.91

Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis (2010) 1.84

Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read (2002) 1.66

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother (2005) 1.59

Implications of gender in chronic Lyme disease. J Womens Health (Larchmt) (2009) 1.57

Preventing varicella-zoster disease. Clin Microbiol Rev (2005) 1.55

The safety profile of varicella vaccine: a 10-year review. J Infect Dis (2008) 1.50

Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer (2008) 1.46

Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis (2011) 1.45

Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45

Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell (2004) 1.45

Factor VIII May Predict Catheter-Related Thrombosis in Critically Ill Children: A Preliminary Study. Pediatr Crit Care Med (2015) 1.44

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42

Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Vaccine (2011) 1.39

HIV testing preferences among young men of color who have sex with men. Am J Public Health (2010) 1.37

Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol (2003) 1.34

Consensus: varicella vaccination of healthy children--a challenge for Europe. Pediatr Infect Dis J (2004) 1.28

Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol (2011) 1.28

Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother (2007) 1.28

Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis (2002) 1.22

Rhinoviruses are a major cause of wheezing and hospitalization in children less than 2 years of age. Pediatr Infect Dis J (2009) 1.21

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol (2011) 1.21

Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir. AIDS (2011) 1.20

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis (2004) 1.19

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis (2006) 1.17

Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis (2008) 1.17

Methodological issues in design and analysis of a matched case-control study of a vaccine's effectiveness. J Clin Epidemiol (2007) 1.16

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis (2010) 1.14

Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS (2009) 1.13

The history and mystery of VZV in saliva. J Infect Dis (2011) 1.10

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J Med Virol (2005) 1.09

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci U S A (2006) 1.09

Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis (2008) 1.09

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics (2007) 1.08

Role of human polyomaviruses in respiratory tract disease in young children. Emerg Infect Dis (2008) 1.05

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab (2012) 1.04

Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics (2007) 1.02

Initiation of antiretroviral therapy in youth with HIV: a U.S.-based provider survey. AIDS Patient Care STDS (2013) 1.02

Lyme disease. Clin Lab Med (2010) 1.01

Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis (2014) 1.00

Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine (2011) 0.99

Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine (2010) 0.98

Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination. Vaccine (2010) 0.96

MoSAIC: Mobile Surveillance for Acute Respiratory Infections and Influenza-Like Illness in the Community. Am J Epidemiol (2014) 0.96

Prevention of pneumococcal infection with vaccines: an evolving story. JAMA (2012) 0.96

Vaccine against Pneumococcal Pneumonia in Adults. N Engl J Med (2015) 0.95

Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol (2010) 0.93

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine (2012) 0.93

The association of overweight and ankle injuries in children. Ambul Pediatr (2008) 0.92

The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation. J Virol (2006) 0.92

Acellular vaccines and resurgence of pertussis. JAMA (2012) 0.91

Varicella vaccine and infection with varicella-zoster virus. N Engl J Med (2005) 0.91

Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact. J Infect Dis (2004) 0.91

Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90

Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient. Am J Infect Control (2011) 0.90

Postpartum mothers' attitudes, knowledge, and trust regarding vaccination. Matern Child Health J (2007) 0.89

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics (2014) 0.89

Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design. Vector Borne Zoonotic Dis (2012) 0.89

Varicella vaccine. N Engl J Med (2007) 0.89

Lyme disease and the orthopaedic implications of lyme arthritis. J Am Acad Orthop Surg (2011) 0.88

Lyme disease. N Engl J Med (2014) 0.88

How can we communicate about vaccines with adolescents and their parents? Clin Pediatr (Phila) (2010) 0.87

Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol (2005) 0.87

Early increases in concentrations of total, LDL, and HDL cholesterol in HIV-infected children following new exposure to antiretroviral therapy. J Pediatr Gastroenterol Nutr (2011) 0.87

Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul (2009) 0.87

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses (2010) 0.86

Risk of herpes zoster in adults immunized with varicella vaccine. J Infect Dis (2008) 0.86

Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retroviruses (2009) 0.86

Reasons physicians accepted or declined smallpox vaccine, February through April, 2003. J Gen Intern Med (2004) 0.85

VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol (2010) 0.85

Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions. J Infect Dis (2006) 0.85

Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system. J Neurovirol (2014) 0.85

Varicella vaccine: rare serious problems--but the benefits still outweigh the risks. J Infect Dis (2003) 0.84

Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer (2012) 0.84

Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women. Obstet Gynecol (2006) 0.83

Transmission of varicella vaccine virus to a non-family member in China. Vaccine (2010) 0.83

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine. Int Rev Immunol (2009) 0.83

Neonatal herpes simplex infection and the Three Musketeers. N Engl J Med (2011) 0.82

Feasibility of using computer-assisted interviewing to enhance HIV test counseling in community settings. Public Health Rep (2009) 0.81

Child care program directors' level of knowledge about asthma and factors associated with knowledge. Clin Pediatr (Phila) (2002) 0.81

Health literacy and adherence to antiretroviral therapy among HIV-infected youth. J Assoc Nurses AIDS Care (2013) 0.81